1. Home
  2. Live Updates
  3. Microrna

Live Breaking News & Updates on Microrna

Stay informed with the latest breaking news from Microrna on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Microrna and stay connected to the pulse of your community

Exosome-Based Assay Shows Diagnostic Sensitivity, Specificity in Pancreatic Cancer

A microRNA assay combined with CA19-9 displayed diagnostic accuracy in the early detection of pancreatic cancer.

United-states , Japan , California , South-korea , China , Ajay-goel , Sciences-at-city-of-comprehensive-cancer-center , Department-of-molecular-diagnostics , Biotech-innovations , Hope-national-medical-center , Basic-sciences , Comprehensive-cancer-center

Novo nabs Cardior in €1B deal, gaining phase II-stage miRNA drug

In what co-founder and CEO Claudia Ulbrich called the “right decision with right partner at the right point in time,” Cardior Pharmaceuticals GmbH agreed to an acquisition by Novo Nordisk A/S in a deal worth up to €1.025 billion (US$1.1 billion) that puts a potentially disease-modifying heart failure candidate in the hands of a big pharma player in the midst of establishing its presence in cardiovascular disease.

Claudia-ulbrich , Novo-nordisk , Cardior-pharmaceuticals-gmb , Pharmaceuticals-gmbh , Novo-nordiska-s , Cardior-pharmaceuticals-gmbh , Cdr-132l , Heart-disease , Mir-132 , Mirna , Bioworld

Novo Nordisk to buy Cardior Pharma for up to $1 billion

Novo Nordisk A/S bought Cardior Pharmaceuticals for $1 billion to enhance cardiovascular treatments. Cardior's microRNA-targeting therapies aim to improve heart function, aligning with Novo's focus on diabetes and obesity history.

Denmark , Danish , Dave-moore , Novo-nordisk , Cardior-pharmaceuticals , Cardior-pharma , Weight-loss-drugs , Cardiovascular-disease , Microrna , Wegovy , Heart-attacks ,

COVID-19 Fallout on Individuals, Economy, and Health System to Last for Years, White Paper Concludes

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

North-carolina , United-states , Louisiana , Indiana , Am-care , New-jersey , Canada , New-york , Madrid , Spain , United-kingdom , Americans

Researchers discover how Zika virus persists in the placenta

Before SARS-CoV-2 and the COVID-19 pandemic, there was the Zika virus epidemic, lasting from 2015 to 2016. The Zika virus can cause serious birth defects and abnormalities.

United-states , Texas , American , Derek-oneil , Megan-craig , Mark-hamilton , Kjersti-aagaard , Maxim-seferovic , Enrico-barrozo , Melissa-suter , Michael-jochum , David-moorshead

Key player in ovarian cancer may have implications for PCOS

Researchers explore the involvement and altered expression of BBOX1-AS1 and microRNA-19b in polycystic ovary syndrome.

China , Hainan , Orawan-pattarawimonchai , Women-health , Children-medical-center , Hainan-women , Microrna , Olycystic-ovary-syndrome , Yndrome , Ntisense , Ssay , Ancer

New method detects microRNA targets at the level of single cells

MicroRNAs are small molecules that regulate gene activity by binding to and destroying RNAs produced by the genes.

Stockholm , Sweden , Danielle-ellis , Marc-friedl , Vaishnovi-sekar , Stockholm-university , Inna-biryukova , Microrna , Iotechnology , Ancer , Ell

MicroRNA affects inflammation in lupus disease: Research

Researchers from Nagoya University's Graduate School of Medicine in Japan have uncovered how microRNA (miRNA) affects inflammation in mice with lupus

Nagoya , Aichi , Japan , Noritoshi-kato , Hiroki-kitai , Hiroshi-suzuki , Nagoya-university , Department-of-molecular-oncology , Suzuki , Department-of-nephrology , Nagoya-university-graduate-school-of-medicine , Graduate-school

MicroRNA Market to hit US$ 846.33 Million by 2030 | Exclusive Report by Growth Plus Reports

NEW YORK, Sept. 7, 2022 /PRNewswire/ -- According to the latest report published by Growth Plus Reports, the global microRNA market is expected to clock US$ 846.33 million by 2030 and to grow

Australia , Japan , United-states , United-kingdom , Argentina , Brazil , China , Canada , Russia , Connecticut , Germany , Italy

MicroRNA Research Antibodies and Kits

In this product brochure, Alpha Laboratories describes its MicroRNA Research Antibodies and Kits

Microrna-research-antibodies , Application-note , Alpha-laboratories , Microrna , Ntibodies , Esearch-kits , Xtraction , Solation , Ucleic-acid ,